
|Articles|May 15, 2020
ASCRS 2020: TearClear CEO shares company's vision, mission for future
Author(s)Alex Delaney-Gesing
Advertisement
Ophthalmology Times' Sheryl Stevenson speaks with Robert Dempsey, TearClear's new CEO, on his goals for the company, its mission and vision in the future of the coronavirus, as well as what to keep an eye out for at the 2020 ASCRS virtual meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tensions rise between STAAR and Broadwood as proposed Alcon deal nears vote
2
Ophthalmic innovation by the decades: The 2010s
3
AAO 2025: Arshad M. Khanani, MD, highlights 3-year results from the GATHER2 open-label extension trial
4
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
5